Intec Pharma, developer of the Accordion Pill gastric retention technology, announced today that it has entered into a collaboration agreement with Impax Laboratories Inc. a leading US specialty pharmaceutical company in order to develop a CNS drug. Intec Pharma will use its proprietary Accordion Pill technology to develop and manufacture the drug while Impax will conduct clinical trials and commercialize the product. The financial terms of the agreement were not disclosed.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2944917)